Literature DB >> 28810652

Expression of prostate stem cell antigen is downregulated during flavonoid-induced cytotoxicity in prostate cancer cells.

Qiang Zhang1, Guangdong Cheng2, Hongbin Qiu1, Yuexin Wang3, Jingtao Wang3, Hui Xu3, Tao Zhang3, Lixin Liu4, Ye Tao1, Zhongjuan Ren1.   

Abstract

Prostate stem cell antigen (PSCA) is expressed in the majority of prostate cancer cases and may be a potential therapeutic target in the treatment of prostate cancer. The present study evaluated the cytotoxicity of three flavonoids (genistein, luteolin and quercetin) towards DU145 prostate cancer cells, and investigated the effect of these flavonoids on PSCA expression. The results demonstrated that genistein, luteolin and quercetin inhibited the growth of DU145 cells in a dose-dependent manner (P<0.05) and induced morphological changes characteristic of apoptosis in DU145 cells. Flow cytometry analysis also indicated that the flavonoids induced S phase cycle arrest in DU145 cells. Notably, it was observed that expression of PSCA was inhibited at the mRNA (P<0.05) and protein levels in DU145 cells following flavonoid treatment compared with the control. These results suggest that flavonoids may be potential therapeutic agents in the treatment and prevention of prostate cancer.

Entities:  

Keywords:  apoptosis; cell cycle arrest; flavonoids; prostate cancer; prostate stem cell antigen

Year:  2017        PMID: 28810652      PMCID: PMC5526134          DOI: 10.3892/etm.2017.4638

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  41 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.

Authors:  N Ahmad; V M Adhami; F Afaq; D K Feyes; H Mukhtar
Journal:  Clin Cancer Res       Date:  2001-05       Impact factor: 12.531

3.  Effects of a high dose, aglycone-rich soy extract on prostate-specific antigen and serum isoflavone concentrations in men with localized prostate cancer.

Authors:  Ralph W deVere White; Alexander Tsodikov; Eschelle C Stapp; Stephanie E Soares; Hajime Fujii; Robert M Hackman
Journal:  Nutr Cancer       Date:  2010       Impact factor: 2.900

4.  Baicalein induced cell cycle arrest and apoptosis in human lung squamous carcinoma CH27 cells.

Authors:  Hong Z Lee; Henry Wing C Leung; Miao Y Lai; Chun H Wu
Journal:  Anticancer Res       Date:  2005 Mar-Apr       Impact factor: 2.480

5.  [Quercetin induces the apoptosis of human PC-3 cells].

Authors:  Qing-Yi Zhu; Rui Hu; Li Liu; Lin Yuan; Wei-Zhou Huang; Long Ma; Xiao-Jian Gu
Journal:  Zhonghua Nan Ke Xue       Date:  2011-09

6.  Anti-PSCA mAbs inhibit tumor growth and metastasis formation and prolong the survival of mice bearing human prostate cancer xenografts.

Authors:  D C Saffran; A B Raitano; R S Hubert; O N Witte; R E Reiter; A Jakobovits
Journal:  Proc Natl Acad Sci U S A       Date:  2001-02-13       Impact factor: 11.205

7.  Flavonoids suppress androgen-independent human prostate tumor proliferation.

Authors:  L M Knowles; D A Zigrossi; R A Tauber; C Hightower; J A Milner
Journal:  Nutr Cancer       Date:  2000       Impact factor: 2.900

Review 8.  New cancer biomarkers deriving from NCI early detection research.

Authors:  Mukesh Verma; Sudhir Srivastava
Journal:  Recent Results Cancer Res       Date:  2003

9.  Antiproliferative and apoptotic effects of a specific antiprostate stem cell single chain antibody on human prostate cancer cells.

Authors:  Foroogh Nejatollahi; Soghra Abdi; Mahdi Asgharpour
Journal:  J Oncol       Date:  2013-12-10       Impact factor: 4.375

10.  Genistein induces G2/M cell cycle arrest and apoptosis via ATM/p53-dependent pathway in human colon cancer cells.

Authors:  Zhiyu Zhang; Chong-Zhi Wang; Guang-Jian Du; Lian-Wen Qi; Tyler Calway; Tong-Chuan He; Wei Du; Chun-Su Yuan
Journal:  Int J Oncol       Date:  2013-05-17       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.